Registry Collecting Data on Children and Young Adults with Eczema
Collects data on people with eczema who use or will use whole-body treatments.
Plain-language title generated from the registry record
Registry title: Registry for Systemic Eczema Treatments
Key facts
- Where
- Baltimore, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 1 and 26 years old?
Source: NCT06136767, who can take part
Where in United States
- Johns Hopkins UniversityBaltimore, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Johns Hopkins University
- Trial code
- NCT06136767
- Record updated
- 7 April 2026
- Original description
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.Read full original descriptionShow less
Registry for Systemic Eczema Treatments
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
Inclusion: Age <26 years old; Current physician diagnosis of atopic dermatitis; Provide signed informed consent if ≥ 18 years old; Provide signed informed consent by parent or legal guardian (if <18 years old) and informed assent if applicable; Subject and/or parent/legal guardian is willing to be contacted in the future by study staff; Seen for clinical care at Johns Hopkins since 1/1/2017; Previously on, currently on, or planning to initiate (within next 6 months) a systemic AD therapy.
Exclusion: Has not received clinical care at Johns Hopkins since 1/1/2017; Age ≥26 years old at the time of registry enrollment; If <18 years old, has a primary caretaker who does not speak English; If <18 years old, parent/legal guardian is unwilling to sign the written informed consent; Does not speak English; Is a foster child.